Show simple item record

dc.contributor.authorNoon, Jason B.
dc.contributor.authorAroian, Raffi V
dc.date2022-08-11T08:09:48.000
dc.date.accessioned2022-08-23T16:44:05Z
dc.date.available2022-08-23T16:44:05Z
dc.date.issued2017-12-01
dc.date.submitted2018-01-18
dc.identifier.citation<p>Parasitology. 2017 Dec;144(14):1845-1870. doi: 10.1017/S003118201700138X. Epub 2017 Aug 3. <a href="https://doi.org/10.1017/S003118201700138X">Link to article on publisher's site</a></p>
dc.identifier.issn0031-1820 (Linking)
dc.identifier.doi10.1017/S003118201700138X
dc.identifier.pmid28770689
dc.identifier.urihttp://hdl.handle.net/20.500.14038/40432
dc.description.abstractSoil-transmitted helminths (STHs) collectively infect one fourth of all human beings, and the majority of livestock in the developing world. These gastrointestinal nematodes are the most important parasites on earth with regard to their prevalence in humans and livestock. Current anthelmintic drugs are losing their efficacies due to increasing drug resistance, particularly in STHs of livestock and drug treatment is often followed by rapid reinfection due to failure of the immune system to develop a protective response. Vaccines against STHs offer what drugs cannot accomplish alone. Because such vaccines would have to be produced on such a large scale, and be cost effective, recombinant subunit vaccines that include a minimum number of proteins produced in relatively simple and inexpensive expression systems are required. Here, we summarize all of the previous studies pertaining to recombinant subunit vaccines for STHs of humans and livestock with the goal of both informing the public of just how critical these parasites are, and to help guide future developments. We also discuss several key areas of vaccine development, which we believe to be critical for developing more potent recombinant subunit vaccines with broad-spectrum protection.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=28770689&dopt=Abstract">Link to Article in PubMed</a></p>
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729844/
dc.rightsCOPYRIGHT: © Cambridge University Press 2017. This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectadjuvants
dc.subjectanthelmintics
dc.subjectprotective immunity
dc.subjectsoil-transmitted helminths
dc.subjectvaccines
dc.subjectImmunoprophylaxis and Therapy
dc.subjectParasitic Diseases
dc.subjectParasitology
dc.titleRecombinant subunit vaccines for soil-transmitted helminths
dc.typeJournal Article
dc.source.journaltitleParasitology
dc.source.volume144
dc.source.issue14
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=4248&amp;context=oapubs&amp;unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/oapubs/3238
dc.identifier.contextkey11383113
refterms.dateFOA2022-08-23T16:44:05Z
html.description.abstract<p>Soil-transmitted helminths (STHs) collectively infect one fourth of all human beings, and the majority of livestock in the developing world. These gastrointestinal nematodes are the most important parasites on earth with regard to their prevalence in humans and livestock. Current anthelmintic drugs are losing their efficacies due to increasing drug resistance, particularly in STHs of livestock and drug treatment is often followed by rapid reinfection due to failure of the immune system to develop a protective response. Vaccines against STHs offer what drugs cannot accomplish alone. Because such vaccines would have to be produced on such a large scale, and be cost effective, recombinant subunit vaccines that include a minimum number of proteins produced in relatively simple and inexpensive expression systems are required. Here, we summarize all of the previous studies pertaining to recombinant subunit vaccines for STHs of humans and livestock with the goal of both informing the public of just how critical these parasites are, and to help guide future developments. We also discuss several key areas of vaccine development, which we believe to be critical for developing more potent recombinant subunit vaccines with broad-spectrum protection.</p>
dc.identifier.submissionpathoapubs/3238
dc.contributor.departmentProgram in Molecular Medicine
dc.source.pages1845-1870


Files in this item

Thumbnail
Name:
_div_class__title__Recombinant ...
Size:
404.7Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

COPYRIGHT: © Cambridge University Press 2017. This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Except where otherwise noted, this item's license is described as COPYRIGHT: © Cambridge University Press 2017. This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.